Reducing the development of Alzheimer’s dementia
(anti-TNF agents)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
Anti-TNF therapies commonly used to treat rheumatoid arthritis have been found to potentially reduce the risk of developing Alzheimer’s dementia among people with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
Rheumatoid arthritis is a chronic disease that causes pain, stiffness, swelling, and destruction of the joints. People with RA often experience limitation in the motion and function of multiple joints. Though joints are the principal body parts affected by RA, inflammation can develop in other organs as well. An estimated 1.3 million Americans have RA, and the disease typically affects women twice as often as men.
A complication of chronic inflammation in RA is amyloidosis, caused by excess deposits of amyloid proteins in different organs, which can cause harmful effects to the normal function of many organs. While people with Alzheimer’s disease are found to have local deposits of a type of amyloid protein—beta-amyloid peptide—in the brain, the actual cause of Alzheimer’s remains unclear. Read more: newswise.com
Alcohol consumption may be suitable as a dietary control for arthritis
Rheumatoid arthritis (RA) is a chronic auto-immune disease that primarily causes painful inflammation around synovial joints (e.g. knees, fingers, elbows). Previous research has suggested that alcohol consumption could have a beneficial effect on the risk of developing RA. Read more: nutraingredients.com
No comments:
Post a Comment